Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AZYO

Aziyo Biologics (AZYO)

Aziyo Biologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AZYO
DataHoraFonteTítuloCódigoCompanhia
22/04/202417:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZYOAziyo Biologics Inc
22/04/202417:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZYOAziyo Biologics Inc
01/04/202418:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
08/09/202309:30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AZYOAziyo Biologics Inc
06/09/202317:05GlobeNewswire Inc.Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting BiomatricesNASDAQ:AZYOAziyo Biologics Inc
30/08/202309:30GlobeNewswire Inc.Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative ProceduresNASDAQ:AZYOAziyo Biologics Inc
14/08/202318:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZYOAziyo Biologics Inc
14/08/202317:05GlobeNewswire Inc.Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix CompanyNASDAQ:AZYOAziyo Biologics Inc
31/07/202317:05GlobeNewswire Inc.Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:AZYOAziyo Biologics Inc
17/07/202317:05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:AZYOAziyo Biologics Inc
13/07/202317:30GlobeNewswire Inc.Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix ProductsNASDAQ:AZYOAziyo Biologics Inc
23/06/202312:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
09/06/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
19/05/202309:15GlobeNewswire Inc.Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeNASDAQ:AZYOAziyo Biologics Inc
12/05/202318:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZYOAziyo Biologics Inc
10/05/202317:05GlobeNewswire Inc.Aziyo Biologics Reports Highest Sales and Gross Profit in Company HistoryNASDAQ:AZYOAziyo Biologics Inc
03/05/202317:05GlobeNewswire Inc.Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023NASDAQ:AZYOAziyo Biologics Inc
20/04/202317:30GlobeNewswire Inc.Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular PortfolioNASDAQ:AZYOAziyo Biologics Inc
07/04/202307:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZYOAziyo Biologics Inc
23/03/202318:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZYOAziyo Biologics Inc
22/03/202317:01GlobeNewswire Inc.Aziyo Biologics Reports Record Full Year 2022 RevenuesNASDAQ:AZYOAziyo Biologics Inc
22/03/202309:30GlobeNewswire Inc.Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue ReconstructionNASDAQ:AZYOAziyo Biologics Inc
20/03/202309:00GlobeNewswire Inc.Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial EnvelopeNASDAQ:AZYOAziyo Biologics Inc
15/03/202317:05GlobeNewswire Inc.Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023NASDAQ:AZYOAziyo Biologics Inc
27/02/202310:15GlobeNewswire Inc.Aziyo Biologics to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:AZYOAziyo Biologics Inc
13/02/202320:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AZYOAziyo Biologics Inc
31/01/202310:00PR Newswire (US)SWK Holdings Provides Portfolio Update Highlighting Recent AchievementsNASDAQ:AZYOAziyo Biologics Inc
09/01/202310:15GlobeNewswire Inc.Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline ResultsNASDAQ:AZYOAziyo Biologics Inc
15/12/202210:00GlobeNewswire Inc.Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings CorporationNASDAQ:AZYOAziyo Biologics Inc
07/12/202218:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AZYOAziyo Biologics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AZYO

Seu Histórico Recente